This compound is a pharmaceutical impurity reference standard, specifically a pyrazinoyl derivative of phenylalanine. It is characterized by the presence of both an amide and a carboxylic acid functional group, along with aromatic and heterocyclic ring systems.
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 1093959-75-1
N-[(2R)-2-Hydroxy-2-(3-hydroxyphenyl)ethyl]-N-methyl-glycine
Pharmaceutical intermediate for phenylephrine related compounds
N-Fmoc-N'-trityl-L-histidine
Protected amino acid for peptide synthesis
Tert-butyl (3R)-3-hydroxypyrrolidine-1-carboxylate
Pharmaceutical intermediate for API synthesis
Methyl 5-(chlorosulfonyl)-2-fluorobenzoate
Pharmaceutical intermediate
N-(Pyrazinylcarbonyl)-L-phenylalanine
Pharmaceutical intermediate
B-[(1R)-3-Methyl-1-[[(2R)-1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)amino]propyl]amino]butyl]boronic Acid
active pharmaceutical ingredient
Bortezomib
active pharmaceutical ingredient
5-methyl-N-[2-(4-sulfamoylphenyl)ethyl]pyrazine-2-carboxamide
pharmaceutical intermediate
3-phenyl-2-(pyrazine-2-carbonylamino)propanoic acid
DWYZPDHMMZGQAP-UHFFFAOYSA-N
C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C2=NC=CN=C2
—